Stearic acid PEG acid - MW 3400 Da

Cat. No.: S164299
Zu bestellen verfügbar
QUALITÄT & REINHEIT MW 3400 Da
Storage
Room temperature
Shipped In
Normal
★
Größe
Deutschland (EU)
USA*
Preis
Menge
50mg
S164299-50mg
—
3 Auf Lager
51,11€
250mg
S164299-250mg
—
2 Auf Lager
161,31€
Enter a quantity for the sizes you want to add.

Übersicht

Stearic acid is an 18 carbon saturated fatty acid lipid with excellent hydrophobicity. PEG modified stearic acid is an excellent amphilphilic polymer with both hydrophilicity and hydrophobility. Pegylated lipids are excellent liposome formation materials that can be used for drug delivery, gene transfection and vaccine delivery as well. These materials can also be used for targeted drug delivery by modifying their surfaces with targeting ligands such as antibodies, peptides.

Spezifikationen

Spezifikationen & Reinheit
MW 3400 Da
Storage
Room temperature
Verschickt in
Normal

Erweiterte Daten

Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeDatumArtikel
C1816040C1816040Certificate of AnalysisMar 08, 2024 S164299
C1816041C1816041Certificate of AnalysisMar 08, 2024 S164299
Chemische und physikalische Eigenschaften
LöslichkeitSolid powder;Soluble in regular aqeous solution as well as most organic solvents;
FAQs und Artikel
Lösungsrechner
Bewertungen

Kundenbewertungen

Application Protocols

The following are general, literature-based procedures for typical uses of stearyl–PEG–acid. They are provided as guidance; they are not validated for this specific SKU. Optimize for your system and consult the CoA/SDS.

A. EDC/NHS coupling of Stearic acid PEG acid to amine-functionalized nanoparticles (aqueous):

  1. Disperse amine-functionalized nanoparticles (e.g., silica–NH2) in 50 mM MES, pH 5.5 (1–5 mg/mL). Sonicate to ensure dispersion.
  2. Dissolve Stearic acid PEG acid in a small volume of DMF or DMSO, then dilute into MES to 1–10 mM final concentration (maintain <10% organic co-solvent).
  3. Add EDC·HCl (2 equiv) and sulfo-NHS (2 equiv) relative to –COOH. Incubate 15–20 min at RT to pre-activate.
  4. Adjust pH to 7.4 and introduce the nanoparticle dispersion containing available –NH2 (10–100 µmol amine per mmol acid). React 1–3 h at RT with gentle mixing.
  5. Quench unreacted active esters with 20 mM ethanolamine (pH 8.0). Wash by centrifugation/filtration until free reagent is removed. Characterize zeta potential and FTIR.

B. Lipid film hydration to blend into liposomes (organic):

  1. Dissolve phospholipids and Stearic acid PEG acid in CHCl3:MeOH (2:1) at desired mol% (e.g., 1–5% of total lipids).
  2. Evaporate to a thin film (rotary evaporation), then high-vacuum dry ≥2 h.
  3. Hydrate with prewarmed buffer while vortexing above the lipid transition temperature. Optional sonication/extrusion to size vesicles.
  4. Analyze particle size (DLS) and surface charge; adjust PEG–acid content to tune colloidal stability.

Notes: Avoid primary amine buffers during coupling; minimize exposure of activated esters to water; and verify loading by acid titration or NMR when possible.

Biological Roles

Biological context (literature/general, material science focus; no clinical claims):

  • Stearyl anchoring: The C18 stearyl chain inserts into hydrophobic domains such as lipid bilayers, polymeric micelles, and hydrophobic nanoparticle coatings, mimicking fatty acyl tails of membrane lipids.
  • PEG corona: The PEG segment forms a hydrated, flexible shell that reduces protein adsorption and nonspecific interactions via steric repulsion and water structuring. This property is widely leveraged to improve colloidal stability and minimize biofouling in research devices and biomaterials.
  • Terminal carboxyl function: Provides a handle for further conjugation to amines (amide formation) or coordination with metal oxide surfaces under basic conditions; it can also modulate surface charge when deprotonated (carboxylate), affecting zeta potential and dispersion stability in buffers.
  • Aggregation behavior: In aqueous media, amphiphiles with one hydrophobic tail and one PEG chain can form micelles or integrate into pre-formed vesicles, with the critical aggregation concentration dependent on PEG length and the ionic state of the carboxyl group.
  • Biodegradation: The stearyl component can undergo oxidative degradation; PEG is generally resistant to many enzymes but can undergo autoxidation at chain ends under harsh conditions. Overall in vivo fate depends strongly on formulation and is not addressed here.

Item-specific biological data (binding, pathways, toxicology): Not specified for this item; refer to CoA/Spec Sheet. Use strictly for research and laboratory applications.

Buffer Applications

This material is not a classical buffering agent. However, buffer choice is critical when using the terminal carboxylic acid for coupling or when dispersing the amphiphile in aqueous systems (literature/general guidance).

Buffers for EDC/NHS coupling to primary amines:

  • MES (2-(N-morpholino)ethanesulfonic acid), pH 4.7–6.0: favored for activation of –COOH with EDC, limiting competing amine protonation and minimizing hydrolysis rate of O-acylisourea intermediates.
  • After activation, coupling to amines is often performed by adjusting to pH 7.0–8.0 (e.g., phosphate or HEPES). Avoid Tris during activation/coupling as it can quench active esters.
  • Ionic strength: 0–150 mM NaCl can be used to modulate electrostatics; higher salt can screen repulsion between carboxylates during assembly.

Dispersing and micellization:

  • Partial neutralization with NaHCO3 or NaOH to pH ~7.4 improves water dispersibility (carboxylate formation), but excessive base may increase ester hydrolysis over time.
  • Co-solvent buffering: 5–20% ethanol or isopropanol in buffer can help solubilize PEG–lipids during assembly without resorting to high levels of aprotic solvents.

Practical notes:

  • Filter buffers (0.22 µm) to reduce particulates before forming thin films or hydrating dried films.
  • Work at lower temperatures when possible to limit hydrolysis of activated esters; perform coupling promptly after activation.

Item-specific buffer compatibility data: Not specified for this item; refer to CoA/Spec Sheet.

Green Alternatives

Sustainability considerations focus on solvent choices and polymer/lipid selection rather than the core chemistry itself, which combines a petrochemical PEG with a biobased fatty acid (stearic acid is commonly derived from natural fats).

Greener processing options (literature/general):

  • Solvent substitution:
    • Replace DMF/NMP (reproductive toxicants) with safer alternatives where possible, e.g., dimethyl carbonate (DMC) or ethyl acetate for film casting, or aqueous MES buffer with limited ethanol as co-solvent for EDC/NHS activation.
    • Prefer 2-MeTHF or cyclopentyl methyl ether (CPME) over CH2Cl2/CHCl3 for certain dissolution/casting steps, acknowledging that PEG segments may require a small polar co-solvent for full solvation.
  • Aqueous coupling: Employ water/saline buffers with sulfo-NHS to enhance EDC efficiency and reduce organic solvent usage; maintain 0–10% ethanol or isopropanol as green co-solvents to aid solubility.
  • Energy usage: Conduct film hydration and self-assembly near the minimum effective temperature; use vacuum-assisted solvent removal to avoid high-temperature drying.

Trade-offs:

  • PEG solubility frequently necessitates polar aprotic solvents; greener ethers or alcohols may not fully dissolve higher-Mn PEG–lipids without heating or co-solvents.
  • Replacing carbodiimides with enzymatic or organocatalytic esterification can be greener but may be incompatible with the ester linkage already present and with heterogeneous substrates.

Comparison table (general):

  • DMF/NMP vs aqueous MES/ethanol: Aqueous system reduces hazard and waste but may increase hydrolysis of activated esters—work quickly and at lower temperatures.
  • CHCl3:MeOH vs 2-MeTHF:EtOH: The greener pair lowers halogenated waste; verify solubility and film quality empirically.
Pharmaceutical Uses

No therapeutic claims are made. For research and formulation development contexts (literature/general):

  • Excipient role: PEGylated stearates are commonly explored as surfactants/emulsifiers and steric stabilizers in experimental lipid nanoparticles, micelles, and emulsions. The stearyl tail anchors in hydrophobic phases while the PEG–acid corona controls interfacial properties and reduces aggregation.
  • Conjugation handle: The terminal –COOH enables covalent attachment of targeting ligands or polymers (research use), allowing construction of model biomimetic surfaces and prototype delivery carriers in preclinical formulation studies.
  • Process aids: Improve wetting and dispersion of hydrophobic actives in screening formulations and assist in film casting for solid dispersions, when compatible with the active and processing conditions.
  • Regulatory perspective: Specific pharmacopeial monographs may exist for certain PEG–stearate excipients (e.g., macrogol stearates), but the exact conformance for this item is unknown.

Item-specific regulatory/grade status:

  • Pharmacopoeial status, GMP/EXCi-Pilot suitability, residual solvent/metal limits: Not specified for this item; refer to CoA/Spec Sheet.

Notes for formulation scientists:

  • Verify PEG molecular weight distribution and acid number to calculate functional density in the final formulation.
  • Assess compatibility with actives and other excipients; monitor for ester hydrolysis under high pH or elevated temperature storage in aqueous media.
  • This product is designated: For research use only.
Physical Properties

Item-specific properties: Not specified for this item; refer to CoA/Spec Sheet.

General/literature characteristics for stearyl–PEG–acid materials (qualitative; PEG length dependent):

  • Physical state: waxy solid to semi-solid at ambient temperature. The stearyl segment confers a relatively high softening point; increasing PEG length typically increases hydrophilicity and may depress crystallinity of the alkyl chain domain.
  • Solubility profile (qualitative):
    • Water: limited direct solubility; may disperse or form micelles/aggregates above a critical aggregation concentration, especially when partially neutralized to the carboxylate. Longer PEG increases aqueous dispersibility.
    • Organic solvents: soluble in polar organics (DMSO, DMF, NMP), halogenated solvents (CHCl3, CH2Cl2), and hot alcohols; variably soluble in acetone/ACN; limited solubility in nonpolar alkanes due to PEG segment.
  • Partitioning: amphiphilic behavior; the stearyl chain strongly partitions into hydrophobic phases and lipid membranes, while the PEG–acid terminus prefers polar/aqueous environments.
  • Acid–base: terminal –COOH is a weak acid; apparent pKa typically decreases slightly relative to simple monocarboxylic acids due to local microenvironment and PEG hydration (literature: carboxylates on PEGylated amphiphiles often exhibit effective pKa in the ~4–5 range, system-dependent). Exact pKa for this item: Not specified for this item; refer to CoA/Spec Sheet.
  • Thermal behavior: PEG segments show a glass transition and melting transitions that vary with n; stearyl chains display melting near that of long-chain alkyl domains. Exact MP/BP, density, and refractive index: Not specified for this item; refer to CoA/Spec Sheet.

Note: All quantitative values (mp, bp, density, logP) are PEG-length dependent and should be taken from the specific batch CoA.

Quality and Grades

Item-specific grade/purity: Not specified for this item; refer to CoA/Spec Sheet.

Interpretation and expectations for PEG–lipid materials (general):

  • PEG polydispersity: Unless explicitly labeled as discrete-mass (monodisperse) PEG, most PEG-containing reagents are polydisperse, described by number-average (Mn) and weight-average (Mw) molecular weights and dispersity (Ð). The effective functionality per mole depends on the PEG length distribution.
  • Functional end-group fidelity: For “PEG acid” ends, residual hydroxyl or ester-capped impurities can be present at low levels in typical manufacturing. End-group titration, NMR integration, and FTIR are common QC tools to confirm the –COOH content.
  • Residual solvents and volatiles: High-boiling solvents (DMF, toluene) can be present at trace levels, managed by vacuum drying. Specific residual limits: Not specified for this item; refer to CoA/Spec Sheet.
  • Metals/ash/UV impurities: Not specified for this item; refer to CoA/Spec Sheet. For applications in surfaces or nanomaterials, low UV background and low ash content are often preferred.
  • Acid number: Often used to quantify –COOH functionality per gram for PEG acids. Item-specific value: Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers and antioxidants: Not typically added for PEG–stearate acids unless declared. Item-specific stabilizers: Not specified for this item; refer to CoA/Spec Sheet.

Recommendations:

  • Request the CoA for exact Mn/Mw, Ð, residual solvent, and end-group purity.
  • For quantitative coupling or surface grafting, standardize by acid number or perform a small-sample neutralization to verify functional loading.
Reaction and Applications

This reagent functions as a lipid–PEG building block with a terminal carboxylic acid suitable for covalent coupling and interfacial assembly.

Representative applications (literature/general):

  • Carbodiimide-mediated conjugation: The –COOH terminus can be activated with EDC (± NHS/sulfo-NHS) and coupled to primary amines on nanoparticles (silica–NH2, Fe3O4–NH2), proteins/peptides (for research chemistry only), and polymer surfaces to yield amide-linked PEGylated interfaces with a hydrophobic stearyl anchor.
  • Self-assembly and coatings: The stearyl chain embeds into hydrophobic matrices (liposomes, polymer films, hydrophobic nanoparticles), presenting a PEG–acid corona that reduces nonspecific adsorption and provides anionic sites for further chemistry or colloidal stabilization.
  • Micelle formation and nanocarriers: In mixed micelles or lipid nanoparticles, stearyl–PEG–acid can tune corona charge and hydration, impacting particle size and stability. The acid can be partially neutralized to adjust zeta potential.
  • Layer-by-layer assembly: The carboxylate (at neutral/basic pH) participates in electrostatic layer formation with polycations (e.g., PEI), enabling build-up of multilayer coatings on hydrophobic cores.
  • Surface density control: Varying feed ratios of stearyl–PEG–acid to other amphiphiles (e.g., phospholipids) modulates grafting density and chain conformation (mushroom vs brush), influencing protein resistance.

Practical tips:

  • Use freshly prepared EDC/NHS active esters; minimize aqueous exposure time to limit hydrolysis.
  • Control pH: activation is efficient around pH 4.7–6.0 (MES), coupling proceeds upon mixing with amines buffered near pH 7–8.
  • For film hydration, anneal above the stearyl softening/melting region to promote uniform incorporation.

Item-specific application validations: Not specified for this item; refer to CoA/Spec Sheet.

Reaction Conditions

General literature guidance for coupling and assembly; adjust based on specific PEG length and substrate.

Carbodiimide-mediated amide coupling (–COOH to –NH2):

  • Solvent/buffer: MES (50 mM, pH 5.0–6.0) ± 0–20% DMF or DMSO for solubility.
  • Reagents: EDC·HCl (1.1–2.0 equiv per –COOH) with NHS or sulfo-NHS (1.0–2.0 equiv) to form a more stable NHS ester.
  • Procedure: Pre-activate acid 10–30 min at room temperature, then add amine-bearing substrate in pH 7.2–8.0 buffer (HEPES or phosphate). Reaction 1–4 h at RT often suffices; longer times may increase hydrolysis of active ester.
  • Notes: Avoid primary amine buffers (Tris) during activation/coupling; maintain moderate ionic strength to reduce nonspecific aggregation.

Acid chloride route (anhydrous, for organic-soluble amines/alcohols):

  • Reagents: Oxalyl chloride (2–4 equiv) with catalytic DMF in CH2Cl2 or toluene, 0 °C to RT, 1–3 h, then evaporate and couple to amine/alcohol with base (e.g., DIPEA) at 0–25 °C. Stringent dryness required.
  • Caution: Acid chloride formation can compromise ester linkages if overheated or in presence of nucleophiles; conduct small-scale trials.

Film casting and hydration (assembly):

  • Dissolve in CHCl3:MeOH (2:1), cast thin film, dry under vacuum ≥2 h, hydrate with buffer above the softening temperature while vortexing/sonicating to form micelles or integrate into lipid systems.

Yields and analytics:

  • Monitor coupling by disappearance of acid proton (NMR), FTIR (C=O shifts), or by TNBS assay for residual amines on surfaces. Typical surface coupling efficiencies vary widely with substrate and conditions.

Item-specific conditions and performance: Not specified for this item; refer to CoA/Spec Sheet.

Safety and Handling

Regulatory/SDS information for this item:

  • GHS classification, signal word, pictograms, H-statements: Not specified for this item; refer to SDS.

General safety considerations for PEGylated fatty acids (literature/general):

  • Expected hazards: typically considered low acute toxicity and low volatility; may cause mild skin/eye irritation. Dust generation is minimal for waxy materials, but avoid aerosols. Handle as a chemical of unknown hazard and consult the SDS.
  • PPE: wear lab coat, safety glasses or goggles, and appropriate chemical-resistant gloves (e.g., nitrile). Use in a well-ventilated area or fume hood when dissolving in organic solvents (DMF, DMSO, CHCl3) to avoid solvent exposure.
  • Incompatibilities: strong oxidizers can degrade the alkyl chain; strong bases/acids can hydrolyze ester linkages over time; dehydrating agents/acid chlorides may activate/modify the terminal carboxyl. Avoid prolonged exposure to elevated temperatures that can accelerate oxidation or hydrolysis.
  • Thermal/combustion: organic combustible solid; in case of fire use CO2, dry chemical, or foam; combustion can produce CO/CO2 and irritating fumes.
  • First aid (overview; follow SDS):
    • Skin: wash with soap and water; remove contaminated clothing.
    • Eyes: rinse cautiously with water for several minutes; remove contacts if easy; seek medical attention if irritation persists.
    • Ingestion: rinse mouth; do not induce vomiting; seek medical advice.
    • Inhalation (dust/solvent vapors): move to fresh air; seek medical attention if symptoms occur.
  • Waste: dispose according to local regulations; avoid release to the environment. Solvent-containing solutions must follow solvent-specific waste streams.

Always defer to the SDS provided with the batch for authoritative guidance.

Solvent Selection

Amphiphilic profile (general): Stearic acid PEG acid bears a hydrophobic stearyl chain and a hydrophilic PEG–carboxyl terminus. Solvent choice should effectively solvate the PEG domain while accommodating the hydrophobic anchor.

Useful solvent systems (literature/general guidance):

  • Polar aprotics (excellent for dissolution and coupling): DMSO, DMF, NMP. Advantages: dissolve PEGylated species and many coupling reagents (EDC/HOBt, HATU, TBTU). Consider using anhydrous grades for moisture-sensitive steps.
  • Halogenated organics: CHCl3, CH2Cl2. Useful for film formation, lipid blending, and casting prior to hydration. Combine with small amounts of methanol/ethanol to aid PEG solvation if needed.
  • Alcohols: methanol, ethanol, isopropanol. Hot alcohols can dissolve many PEG–lipids; be mindful of potential ester exchange under strongly acidic/basic conditions.
  • Aqueous buffers: direct dissolution may be limited; partial neutralization (e.g., with NaHCO3) or addition of co-solvent (5–20% v/v DMSO/DMF) can aid solubilization for coupling to amines in water-compatible protocols.

Selection tips:

  • For carbodiimide chemistry to amines on surfaces/particles, use MES buffer (pH 4.7–6.0) with 0–20% DMF as co-solvent to maintain clarity without hydrolyzing active esters too rapidly.
  • For film hydration to make micelles or to blend with phospholipids, dissolve in CHCl3:MeOH (2:1), dry to a thin film, then hydrate above the softening temperature.
  • Avoid strong bases in protic solvents for extended periods to limit ester cleavage between stearyl and PEG segments.

Comparison (general):

  • Versus unmodified stearic acid: vastly improved dispersibility in polar media and aqueous systems.
  • Versus neutral PEG–stearate: the –COOH terminus enables covalent conjugation (e.g., to amines) at the cost of pH-sensitive charge.
Storage and Reconstitution

Item-specific storage/shipping (from product data):

  • Storage conditions: Room temperature.
  • Shipped in: Normal conditions.

General best practices for PEG–lipid acids:

  • Store in a tightly sealed container, protected from moisture and air to minimize hydrolysis and oxidative degradation of the hydrocarbon chain. Inclusion of desiccant is recommended.
  • Avoid prolonged exposure to elevated temperatures and direct light. For long-term storage, a cool, dry place is preferable. If the product is supplied as a film or powder, maintain under inert gas if feasible.
  • After opening, promptly recap and, if practical, purge headspace with dry nitrogen/argon.

Reconstitution guidance (literature/general):

  • For organic stock solutions: dissolve at 10–100 mM in anhydrous DMSO, DMF, CHCl3, or CHCl3:MeOH (2:1) depending on downstream use. Store aliquots at 2–8 °C or −20 °C to limit repeated warming; bring to room temperature before opening to avoid condensation. Exact shelf-life for solutions: Not specified for this item; refer to CoA/Spec Sheet.
  • For aqueous use: prepare dispersions in MES or phosphate buffer with 0–10% ethanol/DMF co-solvent, optionally adjusting pH to partially neutralize the acid for improved solubility. Use freshly prepared solutions to minimize hydrolysis of activated intermediates.
  • Freeze–thaw: Solid material tolerates ambient storage; solutions may precipitate upon cooling. Avoid repeated freeze–thaw of concentrated stocks; aliquot when preparing solutions.

Research use only: yes (per product data). For definitive stability, purity, and reconstitution limits, consult the batch CoA/Spec Sheet.

Structure and Identity

Item-specific identifiers: Not specified for this item; refer to CoA/Spec Sheet.

  • SKU: S164299
  • Product name: Stearic acid PEG acid
  • Storage conditions (product data): Room temperature; shipped under normal conditions.

General structural description (literature/general):

  • Stearic acid PEG acid typically denotes an amphiphilic conjugate composed of a C18 saturated fatty acyl chain (stearate, CH3–(CH2)16–CO–) covalently linked to a poly(ethylene glycol) chain (–O–CH2–CH2– repeated n times), terminating in a free carboxylic acid group (–COOH). A common motif is stearyl–O–(PEG)n–COOH or stearyl–(PEG)n–O–CH2–COOH, depending on linker chemistry.
  • Functional groups present: long aliphatic chain (hydrophobic), ether backbone (PEG), terminal carboxylic acid (hydrophilic, ionizable), and often an ester linkage connecting the lipid to PEG.
  • Amphiphile class: lipid–polymer conjugate (PEGylated fatty acid), capable of self-assembly and surface anchoring via the stearyl segment while presenting a hydrophilic, weakly acidic PEG terminus.
  • Stereochemistry: none expected on the main chain; all-carbon stearate is achiral; PEG repeat units are achiral.

Formula, molecular weight, and identifiers:

  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet (note: PEG length n determines a distribution of MW; PEGs are typically polydisperse unless otherwise stated).
  • CAS, CID, InChIKey, SMILES: Not specified for this item; refer to CoA/Spec Sheet.

2D structure in words (general): a long C18 chain linked via an ester to a flexible PEG chain ending with a –COOH headgroup.

Synthetic Utility

Functional features:

  • Terminal carboxylic acid: supports amide bond formation with primary/secondary amines (EDC/NHS; HATU; DIC/DMAP for esterification to alcohols) and can be converted to acid chlorides (e.g., with oxalyl chloride) for subsequent acylation under strictly anhydrous conditions.
  • Stearyl anchor: provides hydrophobic attachment to lipids, polymers, and surfaces; enables phase transfer or interfacial localization of conjugates.
  • PEG spacer: imparts water compatibility and spatial separation of functional groups from surfaces, enhancing accessibility and reducing steric hindrance.

Use cases (literature/general):

  • Synthesis of amphiphilic conjugates: Attach dyes, chelators, peptides, or polymers to the PEG–acid, yielding stearyl-anchored, PEG-spaced functional motifs for surface display.
  • Surface modification: Covalent grafting to amine-rich surfaces (e.g., APTES-modified silica) to form dense PEG brushes with hydrophobic anchors intercalated into hydrophobic coatings.
  • Block copolymer analogs: Form mixed assemblies with phospholipids or PLA/PCL to tune hydrophilic–lipophilic balance (HLB) and colloidal stability.

Practical guidance:

  • Quantify loading using acid number titration or 1H NMR end-group integration before stoichiometric coupling.
  • Dry thoroughly under high vacuum at ambient to 40 °C to remove residual moisture that can quench activations.
  • If preparing acid chlorides, minimize exposure to base and moisture to protect the stearyl–PEG ester linkage from transesterification or hydrolysis.

Item-specific reactivity data and yields: Not specified for this item; refer to CoA/Spec Sheet.

Target Specificity

Not applicable. This product is a chemical amphiphile (PEGylated stearate with terminal –COOH), not a biological targeting reagent or antibody. It does not have intrinsic antigen/epitope specificity.

If used to immobilize ligands, the specificity arises from the appended molecule or biomacromolecule, not from Stearic acid PEG acid itself.

Häufig gestellte Fragen

How should this product be stored?
Store at room temperature.
How is this product shipped?
This product ships under standard ambient conditions. No temperature-controlled packaging is required.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.